Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

MoneyGram Partners Ebix To Offer Inward Remittance In India

Published 01/14/2020, 07:25 AM
Updated 07/09/2023, 06:31 AM

MoneyGram International, Inc. (NASDAQ:MGI) has tied up with Ebix, Inc. (NASDAQ:EBIX) , a leading international supplier of On-Demand software and e-commerce services.

Per the agreement, Ebix’s wholly-owned subsidiary, EbixCash will be the exclusive partner of MoneyGram in India. Its customers will be able to reach out to MoneyGram to seamlessly receive money from family and friends around the world.

Ebix’s huge presence in India makes it a perfect fit for MoneyGram. Ebix has 320,000 distribution outlets spread across 768 districts, 4,000 cities, and more than 75,000 villages, giving it a significant presence in rural India.

Per the deal, MoneyGram will be handling inward remittances to India. The country is expected to see inward remittances of $3 billion annually. This makes India the leading remittance-receiving country in Asia and an attractive market for MoneyGram.

This move also reflects MoneyGram’s strategy to expand its international operations at a time when revenue growth in the United States is difficult to achieve, given intense competition from new fintech players such as TransferWise, Azimo, Remitly and WorldRemit, to name a few.

These companies utilize online and mobile platforms to transfer money, which makes their services more cost-effective and efficient. Unlike MoneyGram, which has to pay a commission to brick-and-mortar agents that originate the transfers, most of the players steer clear of the same, because of their use of digital channels. This helps them save a large chunk of operating cost and enables them to enjoy better operating margins.

It is to be noted that revenues from MoneyGram’s U.S. operations declined by 1.4% and 13% in 2017 and 2018, respectively. Over the past two years, its market capitalization has eroded by nearly 72%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The stock has lost 8.5% against the industry’s growth of 16.5% in the past year. This performance pales in comparison with the price gains of 5.3% for Square (NYSE:SQ), 51.4% for Western Union Co. (NYSE:WU) and 27.5% for PayPal Holdings, Inc. (NASDAQ:PYPL) .

MoneyGram is making continuous investments to develop its digital platforms. Notably, the company witnessed a record-breaking online transaction growth during the most recent holiday shopping season.

MoneyGram carries a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report

Ebix, Inc. (EBIX): Free Stock Analysis Report

MoneyGram International Inc. (MGI): Free Stock Analysis Report

The Western Union Company (WU): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.